Skip to content

PressReach

SEARCH icon
  • Investing
  • Featured
  • Market
  • Biotech
  • Oil & Gas
  • Mining
  • Gaming
  • Tech
  • Crypto
  • More
    • Health
    • Entertainment
    • Real Estate
    • Cannabis
    • ESG
    • Financial
    • Food & Beverage
    • Industrials
    • Travel & Hospitality
    • Trading Tips
    • Investing Videos
Search

SEARCH FOR AN ARTICLE

  • Investing
  • Featured
  • Market
  • Biotech
  • Oil & Gas
  • Mining
  • Gaming
  • Tech
  • Crypto
  • More
    • Health
    • Entertainment
    • Real Estate
    • Cannabis
    • ESG
    • Financial
    • Food & Beverage
    • Industrials
    • Travel & Hospitality
    • Trading Tips
    • Investing Videos

PressReach

icon

      HomeJohnson & Johnson’s

      Johnson & Johnson’s

      Jnj Stock Closed Slightly Down as Received FDA Clearance for Its Multiple Myeloma Treatment
      Investing News

      Jnj Stock Closed Slightly Down as Received FDA Clearance for Its Multiple Myeloma Treatment

      October 25, 2022
      The EC has approved J&J’s Tecvayli for the treatment of multiple myeloma.
      Investing News

      The EC has approved J&J’s Tecvayli for the treatment of multiple myeloma.

      August 25, 2022

       

      LATEST NEWS

      • Investing News Meta’s Q1 2026 Earnings Overview
      • Investing News NXP Semiconductors’ Earnings Exceed Expectations
      • Investing News Visa’s Stock Surge on Strong Earnings
      • Investing News Corning Shares: A Long-term Opportunity
      • Investing News Meta’s AI Strategy Unveiled

      PressReach

      All logos, trade names and/or trademarks, artwork and associated imagery are trademarks and/or copyright material of their respective owners.

      • Advertisers
      • Privacy Policy
      • Terms of Use
      • DMCA Policy
      • Disclaimer
      • Contact Us

      SUBSCRIBE

      To get email updates from PressReach.

      I want e-mail alerts, updates, and offers and agree to the PressReach privacy policy.

      Market Jar Media Inc. © 2026